PMC:7755033 / 74394-74486 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7755033","sourcedb":"PMC","sourceid":"7755033","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7755033","text":"1P9U) in comparison to the FDA approved standard reference drugs (Oberadilol and Poziotinib)","tracks":[{"project":"LitCovid-sentences","denotations":[{"id":"T705","span":{"begin":0,"end":92},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T705","pred":"source","obj":"LitCovid-sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-sentences","color":"#93eca3","default":true}]}]}}